These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16773493)

  • 1. Tumor buds show reduced expression of laminin-5 gamma 2 chain in DNA mismatch repair deficient colorectal cancer.
    Shinto E; Baker K; Tsuda H; Mochizuki H; Ueno H; Matsubara O; Foulkes WD; Jass JR
    Dis Colon Rectum; 2006 Aug; 49(8):1193-202. PubMed ID: 16773493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic comparison of hereditary nonpolyposis colorectal cancer associated with MSH2 and MLH1 and colorectal cancer from the general population.
    Shashidharan M; Smyrk T; Lin KM; Ternent CA; Thorson AG; Blatchford GJ; Christensen MA; Lynch HT
    Dis Colon Rectum; 1999 Jun; 42(6):722-6. PubMed ID: 10378595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers.
    Kuismanen SA; Holmberg MT; Salovaara R; de la Chapelle A; Peltomäki P
    Am J Pathol; 2000 May; 156(5):1773-9. PubMed ID: 10793088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population.
    Lin KM; Shashidharan M; Ternent CA; Thorson AG; Blatchford GJ; Christensen MA; Lanspa SJ; Lemon SJ; Watson P; Lynch HT
    Dis Colon Rectum; 1998 Apr; 41(4):428-33. PubMed ID: 9559626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
    Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
    N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer.
    Raedle J; Trojan J; Brieger A; Weber N; Schäfer D; Plotz G; Staib-Sebler E; Kriener S; Lorenz M; Zeuzem S
    Ann Intern Med; 2001 Oct; 135(8 Pt 1):566-76. PubMed ID: 11601928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
    Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
    J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.
    Vasen HF; Stormorken A; Menko FH; Nagengast FM; Kleibeuker JH; Griffioen G; Taal BG; Moller P; Wijnen JT
    J Clin Oncol; 2001 Oct; 19(20):4074-80. PubMed ID: 11600610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test.
    Mathiak M; Rütten A; Mangold E; Fischer HP; Ruzicka T; Friedl W; Propping P; Kruse R
    Am J Surg Pathol; 2002 Mar; 26(3):338-43. PubMed ID: 11859205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes.
    Wang Y; Friedl W; Lamberti C; Jungck M; Mathiak M; Pagenstecher C; Propping P; Mangold E
    Int J Cancer; 2003 Feb; 103(5):636-41. PubMed ID: 12494471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
    Aaltonen LA; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick RB; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin JP; de la Chapelle A
    N Engl J Med; 1998 May; 338(21):1481-7. PubMed ID: 9593786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.
    Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C
    Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer.
    Casey G; Lindor NM; Papadopoulos N; Thibodeau SN; Moskow J; Steelman S; Buzin CH; Sommer SS; Collins CE; Butz M; Aronson M; Gallinger S; Barker MA; Young JP; Jass JR; Hopper JL; Diep A; Bapat B; Salem M; Seminara D; Haile R;
    JAMA; 2005 Feb; 293(7):799-809. PubMed ID: 15713769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
    van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
    Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seven novel MLH1 and MSH2 germline mutations in hereditary nonpolyposis colorectal cancer.
    Krüger S; Plaschke J; Pistorius S; Jeske B; Haas S; Krämer H; Hinterseher I; Bier A; Kreuz FR; Theissig F; Saeger HD; Schackert HK
    Hum Mutat; 2002 Jan; 19(1):82. PubMed ID: 11754112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach.
    Gille JJ; Hogervorst FB; Pals G; Wijnen JT; van Schooten RJ; Dommering CJ; Meijer GA; Craanen ME; Nederlof PM; de Jong D; McElgunn CJ; Schouten JP; Menko FH
    Br J Cancer; 2002 Oct; 87(8):892-7. PubMed ID: 12373605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
    Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
    Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.
    Shin KH; Shin JH; Kim JH; Park JG
    Cancer Res; 2002 Jan; 62(1):38-42. PubMed ID: 11782355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.